Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hope on the Horizon: New and Future Therapies for Sickle Cell Disease

1 Sept 2023

Abstract excerpt

This article provides an overview of conventional, new, and future treatment options for sickle cell disease (SCD), a genetic disorder affecting the production of hemoglobin. Current treatments include hydroxyurea, a conventional SCD treatment that increases the levels of fetal hemoglobin, and new treatments such as voxelotor, a recently approved SCD treatment that selectively binds hemoglobin, preventing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemoglobinopathies and Related Disorders
Share to Iron Metabolism and Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37685759
DOI: 10.3390/jcm12175692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hope on the Horizon: New and Future Therapies for Sickle Cell DiseasePMID 37685759Read ↗

Current and emerging treatments for sickle cell diseaseSemantic proximity Read ↗

Sickle Cell Anemia and Antisickling Agents Then and NowSemantic proximity Read ↗

Sickle Cell Disease: From Genetics to Curative ApproachesSemantic proximity Read ↗

Sickle Cell Disease.Semantic proximity Read ↗

Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular levelSemantic proximity Read ↗

Sickle Cell DiseaseSemantic proximity Read ↗

Hydroxyurea in the sickle cell disease modern eraSemantic proximity Read ↗

Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approachesSemantic proximity Read ↗

Drug Therapies for the Management of Sickle Cell DiseaseSemantic proximity Read ↗

Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell diseaseSemantic proximity Read ↗

Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.Semantic proximity Read ↗

Sickle Cell Disease: Genetics, Cellular and Molecular Mechanisms, and TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.